株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

世界の禁煙薬市場:2016〜2020年

Global Smoking Cessation Drugs Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 357354
出版日 ページ情報 英文 74 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。
Back to Top
世界の禁煙薬市場:2016〜2020年 Global Smoking Cessation Drugs Market 2016-2020
出版日: 2016年04月27日 ページ情報: 英文 74 Pages
概要

喫煙の悪影響に関する意識が高まり、多くの喫煙者が禁煙もしくは喫煙本数の削減に努めています。こうした流れの中で、禁煙製品が人々の間に広がっています。世界の禁煙薬市場は、2016〜2020年にかけ、CAGR18.16%で拡大すると予測されています。

当レポートでは、世界の禁煙薬市場の現状と2020年までの成長見通し、市場の動向と課題、地域別動向、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 世界の煙草統計:年間一人当たりの消費量

第6章 疫学

第7章 喫煙の健康への影響

第8章 煙草に対する法規制

  • 企業に及ぼす禁煙の影響
  • 個人に対する経済的負担

第9章 パイプライン分析

第10章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第11章 タイプ別市場セグメンテーション

  • 世界の禁煙薬剤市場
  • 世界のNRT市場
  • 世界のe-シガレット市場

第12章 入手性別市場セグメンテーション

  • 処方薬
  • OTC薬

第13章 地域別市場セグメンテーション

  • 地域別市場
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第14章 市場促進因子

  • 喫煙者の増加
  • 10代喫煙者の増加
  • 民間認識プログラムの数
  • タバコによるリスクへの認識の高さ

第15章 促進因子の影響

第16章 市場の課題

  • 薬剤および治療による副作用
  • 治療後の再開
  • 薬剤研究開発の脆弱さ

第17章 促進因子と課題の影響

第18章 市場動向

第19章 ベンダー環境

  • 競合シナリオ
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
  • その他の注目すべきベンダー

第20章 付録

第21章 Technavioについて

図表

図表
  • Exhibit 01: Product offerings
  • Exhibit 02: Common health effects caused by smoking
  • Exhibit 03: Smoking cessation products: Pipeline portfolio
  • Exhibit 04: Discontinued projects
  • Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global smoking cessation products market by type
  • Exhibit 08: Global smoking cessation products market by type 2015
  • Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
  • Exhibit 10: Global NRTs market 2015-2020 ($ billions)
  • Exhibit 11: Global NRTs market by product 2015
  • Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
  • Exhibit 13: Nicotine patch market by geographical region 2015
  • Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
  • Exhibit 15: Nicotine gum market by geographical region 2015
  • Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
  • Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
  • Exhibit 18: E-cigarette market by geographical region 2015
  • Exhibit 19: Global smoking cessation products market by availability
  • Exhibit 20: Global smoking cessation products market by geography 2015
  • Exhibit 21: Global smoking cessation products market by geography 2020
  • Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
  • Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
  • Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
  • Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
  • Exhibit 26: Impact of drivers
  • Exhibit 27: Impact of drivers and challenges
  • Exhibit 28: Implementation of picture warnings in various countries
  • Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
  • Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
  • Exhibit 32: GlaxoSmithKline: Key takeaways
  • Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
  • Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 35: Imperial Tobacco: Key takeaways
  • Exhibit 36: NJOY: Product categories
  • Exhibit 37: NJOY: Key takeaways
  • Exhibit 38: Pfizer: Business segmentation by revenue 2014
  • Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
  • Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
  • Exhibit 42: Pfizer: Key takeaways
  • Exhibit 43: Reynolds American: Business segmentation by revenue 2014
  • Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 45: Reynolds American: Key takeaways
目次
Product Code: IRTNTR8278

About Smoking Cessation Products

Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.

Technavio's analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American

Other Prominent Vendors

  • 22nd Century Group
  • Alkalon
  • Altria Group
  • Aradigm
  • Arena Pharmaceuticals
  • Ballantyne Brands
  • British American Tobacco (BAT)
  • CB Distributors
  • Cytos Biotechnology
  • Electronics Cigarettes International Group (Victory Electronic Cigarettes)
  • Evotec
  • Gamucci
  • Japan Tobacco
  • Johnson & Johnson
  • LOGIC Technology
  • NAL Pharmaceuticals
  • Nicotek
  • Novartis
  • Revolymer
  • RR Chemicals
  • Selecta Biosciences
  • Target
  • The Harvard Drug Group
  • Vapor
  • VMR Products
  • Walgreens
  • Wal-Mart
  • White Cloud

Market driver

  • High awareness of risks associated with tobacco use
  • For a full, detailed list, view our report

Market challenge

  • Relapse after treatment
  • For a full, detailed list, view our report

Market trend

  • Ban on tobacco advertisements
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: World cigarette statistics: Per capita consumption per year

PART 06: Epidemiology

  • US

PART 07: Health implications of smoking

  • Risk of tobacco smoke on non-smokers

PART 08: Regulations on tobacco use

  • Impact of smoking bans on businesses
  • Economic benefits to individuals

PART 09: Pipeline analysis

  • NAL2762
  • X-22
  • APD356
  • GSK598809
  • SEL-068
  • ARD-1600

PART 10: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 11: Market segmentation by type

  • Global smoking cessation drugs market
  • Global NRTs market
  • Global e-cigarette market

PART 12: Market segmentation by availability

  • Prescription products
  • OTC products

PART 13: Geographical segmentation

  • Global smoking cessation products market by geography 2015-2020
  • Smoking cessation products market in Americas
  • Smoking cessation products market in EMEA
  • Smoking cessation products market in APAC

PART 14: Market drivers

  • Increase in number of smokers
  • Increase in teenage smoking
  • Significant number of public awareness programs
  • High awareness of risks associated with tobacco use

PART 15: Impact of drivers

PART 16: Market challenges

  • Side effects associated with drugs and therapies
  • Relapse after treatment
  • Weak R&D on drugs

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Increase in use of e-cigarettes
  • Increased innovation in smoking cessation products
  • Ban on tobacco advertisements
  • Increased pictorial warnings on cigarette packages

PART 19: Vendor landscape

  • Competitive scenario
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

Back to Top